申请人:Brenneman Jehrod Burnett
公开号:US20130065918A1
公开(公告)日:2013-03-14
The present invention relates to compounds of formula (I):
and pharmaceutically acceptable salts thereof, wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, A and B are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
本发明涉及式(I)的化合物及其药学上可接受的盐,其中R1,R2,R3,R4,R5,R6,A和B的定义如本文所述。本发明还涉及包含这些化合物的制药组合物,使用这些化合物治疗各种疾病和障碍的方法,制备这些化合物的过程以及这些过程中有用的中间体。